google-x
(7)
Ryan Endacott Is Teaching Software to Expect the Weird
From Mizzou hack nights to stratospheric balloons and AI-made games, Ryan Endacott keeps returning to one useful question: how do you make complicated technology feel inviting?
Stas Sokolin
Stas Sokolin is the co-founder and CEO of Amae Health, a specialty integrated-care company for people with severe mental illness. A former impact investor at the Chan Zuckerberg Initiative with earlier stints at Google X and the American Medical Association's Health2047, he started his career as an investment banking analyst at BNP Paribas before setting out to rebuild how the hardest cases in behavioral health are treated - using in-person clinics, multidisciplinary teams, and a data platform built on Palantir. In November 2025 Amae raised a $25 million Series B led by Altos Ventures, pushing its total funding past $50 million.
Sahil Hasan
Sahil Hasan is the CEO and Co-Founder of Dots, a developer-friendly global payouts platform that has processed over $1 billion to more than 1 million gig workers, creators, and contractors in 190+ countries. A UC Berkeley EECS grad with a CMU master's degree, Sahil spent time as a Research Engineer at Google X before co-founding Dots through Y Combinator's S21 batch. The company raised an $8.9M Series A in February 2026 led by DCM Ventures, is profitable, and growing revenue 400% year-over-year.
Kyle Moore
Kyle Moore is co-founder and Software Fellow at Pyka, the Alameda, California company building the world's largest commercially-approved autonomous electric aircraft. A self-taught programmer who started writing code at age 11 from rural Washington, Moore brought firmware and robotics expertise from Google X to help design Pyka's Pelican — a 1,320-lb autonomous electric aircraft now spraying crops across four continents and delivering cargo for the U.S. Air Force. Pyka has raised $95M in total funding and achieved back-to-back FAA authorizations for the largest uncrewed aircraft systems in U.S. commercial history.
Darren Bonnstetter
Darren Bonnstetter is the CEO of Conexiom, a Vancouver-based AI-native platform automating sales order processing for manufacturers and distributors. Appointed in August 2025, he brings a rare blend of mechanical engineering rigor (Iowa State, Stanford MS, Harvard MBA), turnaround consulting at AlixPartners, and climate-tech entrepreneurship - having co-founded and led 280 Earth, a Google X spinout that raised $50M to capture carbon using industrial waste heat. At Conexiom, he leads a 210-person company serving 16 of the top 20 distributors globally, with $170M in total funding backed by Warburg Pincus, Luminate Capital Partners, and ICONIQ Capital.
Anthony Jules
Anthony Jules is the Co-founder and CEO of Robust.AI, a San Carlos, California company building AI-powered collaborative robots for warehouse and logistics operations. A 30-year technology veteran originally from Trinidad and Tobago, Jules began coding at age 11, earned degrees in Computer Science from MIT, and helped scale Sapient Corporation from 3 to 4,000 employees. After co-founding Redwood Robotics (acquired by Google), he led robotics product programs at Google X's Everyday Robot project, then co-founded Robust.AI in 2019 alongside robotics legend Rodney Brooks. The company's Carter robot - which uses eight cameras and no lidar - achieved a 60% productivity increase at DHL Supply Chain on day one, and recently partnered with Foxconn for manufacturing scale-up.
Mark Lee
Mark Lee, MD, PhD is the CEO and Co-Founder of N-Power Medicine, a Redwood City-based company reinventing how oncology clinical trials reach patients. A medical oncologist and scientist trained at Stanford and Harvard, Lee has spent his career at the frontier of personalized medicine - from developing Oncotype DX diagnostics at Genomic Health, to helping build early cancer detection at GRAIL, to leading personalized healthcare at Genentech/Roche. In 2021, he co-founded N-Power Medicine to embed research infrastructure directly into community oncology clinics, combining AI, embedded staff, and real-time registries to dramatically expand clinical trial access. After raising a $72M Series B led by Merck's Global Health Innovation Fund, N-Power acquired Syapse in late 2024 to build the largest community-based prospective clinical research network in oncology.